However, differences in HDL cholesterol from genetic variance have not been associated with differences in coronary heart disease (CHD) risk [4], whereas TG lowering genetically has been associated with CVD reduction, with the same degree of benefit per mg/dL apoB lowering as a reduction in LDL cholesterol [5]. Here, APOB is linked to coronary artery disorder.